Pyxis Oncology (PYXS) Other Working Capital Changes (2020 - 2025)

Pyxis Oncology (PYXS) has 6 years of Other Working Capital Changes data on file, last reported at -$380000.0 in Q4 2025.

• Other Working Capital Changes for Q4 2025 came in at -$380000.0, changed N/A year-over-year; the trailing twelve-month figure through Dec 2025 was -$5.9 million (down 447.61% YoY), and the FY2025 annual result was $629653.0, up 122.55% from the prior year.
• Other Working Capital Changes fell to -$380000.0 in Q4 2025 per PYXS's latest filing, from $530129.0 in the prior quarter.
• Over five years, Other Working Capital Changes peaked at $2.8 million in Q4 2022 and troughed at -$5.2 million in Q4 2023.
• A 5-year average of $8927.1 and a median of $200406.0 in 2024 frame the typical range for Other Working Capital Changes.
• The sharpest annual moves came in 2021 and 2023: Other Working Capital Changes plunged 1943.66% in 2021, then surged 473.71% in 2023.
• A 5-year view of Other Working Capital Changes shows it stood at -$1.5 million in 2021, then surged by 293.8% to $2.8 million in 2022, then tumbled by 285.95% to -$5.2 million in 2023, then soared by 105.41% to $282928.0 in 2024, then sank by 234.31% to -$380000.0 in 2025.
• Business Quant data shows PYXS's Other Working Capital Changes at -$380000.0 in Q4 2025, $530129.0 in Q3 2025, and $333268.0 in Q2 2025.